IGHV4-39 deletion polymorphism does not associate with risk or outcome of multiple sclerosis. by Watson, C, Ramagopalan, S, Morrison, K, Ebers, G, Breden, F

Association between microchimerism and multiple sclerosis in Canadian twins. by Willer, C, Herrera, B, Morrison, K, Sadovnick, A, Ebers, G

Hyperubiquitination of proteins in dilated cardiomyopathy. by Weekes, J, Morrison, K, Mullen, A, Wait, R, Barton, P, Dunn, M

TNO evidence to support CTLA4 as a multiple sclerosis susceptibility gene by Morrison, K, Dyment, D, Willer, C, Risch, N, Sadovnik, A, Ebers, G

CD8+ T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade. by Ensminger, S, Witzke, O, Spriewald, B, Morrison, K, Morris, P, Rose, M, Wood, K

Vitamin-D Receptor and 1-alpha-hydroxylase Genes in Risk and Outcome of Multiple Sclerosis in Canadians by Orton, S, Ramagopalan, S, Handunnetthi, L, Herrrera, B, Lincoln, MR, Morrison, K, Sadovnick, A, Ebers, G

HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination. by Disanto, G, Magalhaes, S, Handel, A, Morrison, K, Sadovnick, A, Ebers, G, Banwell, B, Bar-Or, A

Kinetics of transplant arteriosclerosis in MHC-Class I mismatched and fully allogeneic mouse aortic allografts. by Ensminger, S, Spriewald, B, Witzke, O, Morrison, K, Pajaro, O, Morris, P, Rose, M, Wood, K

Variants in ST8SIA1 do not play a major role in susceptibility to multiple sclerosis in Canadian families. by Ramagopalan, S, Morrison, K, Para, A, Handel, A, Disanto, G, Handunnetthi, L, Orton, S, Sadovnick, A, Ebers, G

A genome-wide scan in forty large pedigrees with multiple sclerosis. by Willer, C, Dyment, D, Cherny, S, Ramagopalan, S, Herrera, B, Morrison, K, Sadovnick, A, Risch, N, Ebers, G

Intragraft interleukin-4 mRNA expression after short-term CD154 blockade may trigger delayed development of transplant arteriosclerosis in the absence of CD8+ T cells. by Ensminger, S, Spriewald, B, Witzke, O, Morrison, K, van Maurik, A, Morris, P, Rose, M, Wood, K

Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. by Orton, S, Ramagopalan, S, Para, A, Lincoln, MR, Handunnetthi, L, Chao, M, Morahan, J, Morrison, K, Sadovnick, A, Ebers, G

Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians by Orton, S, Ramagopalan, S, Para, A, Lincoln, M, Handunnetthi, L, Chao, M, Morahan, J, Morrison, K, Sadovnick, A, Ebers, G

TCR beta polymorphisms and multiple sclerosis. by Dyment, D, Steckley, J, Morrison, K, Willer, C, Cader, M, DeLuca, G, Sadovnick, A, Risch, N, Ebers, G

Risk alleles for multiple sclerosis in multiplex families. by D'Netto, M, Ward, H, Morrison, K, Ramagopalan, S, Dyment, D, DeLuca, G, Handunnetthi, L, Sadovnick, A, Ebers, G

The effects of two polymorphisms on p21cip1 function and their association with Alzheimer's disease in a population of European descent by Yates, S, Zafar, A, Rabai, E, Foxall, J, Nagy, S, Morrison, K, Clarke, C, Esiri, M, Christie, S, Smith, A, Nagy, Z

Methylation of class II transactivator gene promoter IV is not associated with susceptibility to Multiple Sclerosis by Ramagopalan, S, Dyment, D, Morrison, K, Herrera, B, Deluca, G, Lincoln, MR, Orton, S, Handunnetthi, L, Chao, M, Sadovnick, A, Ebers, G

No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis. by Ramagopalan, S, Deluca, G, Morrison, K, Herrera, B, Dyment, D, Orton, S, Bihoreau, M, Degenhardt, A, Pugliatti, M, Sadovnick, A, Sotgiu, S, Ebers, G

A contig of non-chimaeric YACs containing the spinal muscular atrophy gene in 5q13. by Francis, M, Morrison, K, Campbell, L, Grewal, P, Christodoulou, Z, Daniels, R, Monaco, A, Frischauf, A, McPherson, J, Wasmuth, J

Temperature insensitivity of the spin-polarization in Co2MnSi films on GaAs (001) by Branford, W, Singh, L, Barber, Z, Kohn, A, Petford-Long, A, Van Roy, W, Magnus, F, Morrison, K, Clowes, S, Bugoslavsky, Y, Cohen, L